MY ACCOUNT | NEWSLETTER |

Cervical ventroflexion in cats 86 cases (2003-2024).

Clinical evidence update from Journal of feline medicine and surgery


Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of feline medicine and surgery in 2025 evaluated cervical ventroflexion in cats: 86 cases (2003-2024)..

Key Findings

ObjectivesThe aim of this study was to characterise cervical ventroflexion in cats, investigate which diseases are associated with its occurrence and evaluate treatment outcome.MethodsThis retrospective, two-centre study spans the period from 2003 to 2024. The inclusion criteria consisted of complete medical records, presence of cervical ventroflexion, baseline clinicopathological testing and a diagnosis. A descriptive statistical analysis was performed for all cats. Univariable and multivariable analyses were used to compare the feline hypokalaemic myopathy (FHM) group vs all other diagnoses.ResultsA total of 86 cats met the inclusion...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Prognostic Markers Associated with Short-Term Mortality in Dogs Hospitalised with Acute Pancreatitis A Retrospective Study of 192 Cases.

Like0
Dislike0

No light, no problem provision of light during simulated transport does not alter broiler chick performance or welfare outcomes.

Like0
Dislike0

Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs

Like0
Dislike0

CMMB Launches Strategic Partnerships and Global Volunteer Initiatives to Strengthen Health Systems Worldwide

Like0
Dislike0

N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease a double-blind, placebo-controlled clinical trial.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top